Lenalidomide Capsules is used for the treatment of patients with myelodysplastic syndromes (MDS) (MDS).

Lenalidomide is used to treat multiple myeloma. It is a more potent molecular analog of thalidomide, which inhibits tumor angiogenesis, tumor secreted cytokines and tumor proliferation through the induction of apoptosis.

Lenalidomide Capsules suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Lenalidomide Capsules brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Lenalidomide Capsules medicine cost price in India.

The order for Lenalidomide Capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Trade Name: Request you to fill the query form for more details.

Generic Name: Lenalidomide Capsules

Capsules: 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg

TARCEVA (Lenalidomide Capsules

Lenalidomide Capsules is available.

Get In Touch

Lenalidomide Capsules suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Lenalidomide Capsules on prescription and Import License in Patient's Name only.

For overseas patients, Lenalidomide Capsules can be made available in Send your enquiry to find Lenalidomide Capsules in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Lenalidomide Capsules.

FDA panel recommends approval of Epizyme drug for rare cancer For More Details

Lenalidomide/Rituximab PFS Benefit Maintained in Elderly Subgroup With Indolent Non-Hodgkin Lymphoma For More Details